{"disease":{"id":"tingling","name":"tingling","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"cesium","indication_name":"Tingling relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurotox","generic_name":"CESIUM","company_name":"BioActive Nutritional, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"cesium","indication_name":"tingling","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurotox","generic_name":"CESIUM","company_name":"BioActive Nutritional, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"gadolinium","indication_name":"tingling","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurotox","generic_name":"GADOLINIUM","company_name":"BioActive Nutritional, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":16,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02722434","title":"MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT06799351","title":"Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Bernardino Clavo, MD, PhD","has_results":false},{"nct_id":"NCT06706544","title":"Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Bernardino Clavo, MD, PhD","has_results":false},{"nct_id":"NCT03943498","title":"Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03206216","title":"Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Stanford University","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}